Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Creation and assessment of a predictive model utilizing choroid plexus imaging from brain MRI for evaluating anti-TNF-α treatment responses in Crohn’s disease

  • By

  • Mengting Huang

  • Shuo Huang

  • Qinyue Luo

  • Yuting Zheng

  • Hanting Li

  • Ping Han

  • Liangru Zhu

  • Heshui Shi

  • March 6, 2026

Share

Objective:

To identify choroid plexus (CP) based biomarkers using brain MRI and develop a predictive model for clinical remission following anti-TNF-α therapy in Crohn’s disease (CD) patients, enhancing treatment personalization.

Approach:
    Key Findings:
    • The study identified significant correlations between CP imaging metrics and treatment response to anti-TNF-α therapy, suggesting a potential for clinical application.
    • Patients with altered CP characteristics on MRI were more likely to exhibit non-response to treatment, indicating a need for early intervention.
    • The predictive model developed showed potential for clinical application in assessing treatment outcomes, warranting further validation.
    Interpretation:

    The findings suggest that CP imaging may serve as a novel biomarker for predicting anti-TNF-α treatment responses in CD, potentially enhancing personalized treatment strategies.

    Limitations:
    • The study was limited to a single center, which may affect generalizability; future studies should include multiple centers.
    • The sample size may not be large enough to fully validate the predictive model, suggesting a need for larger cohort studies.
    • Long-term follow-up data were not available for all patients, which could impact the assessment of long-term outcomes.
    Conclusion:

    The study highlights the potential of CP imaging as a predictive tool for anti-TNF-α therapy response in Crohn’s disease, warranting further research for clinical implementation and validation in diverse populations.

Original Source(s)

Related Content